Cargando…
Utility of a next‐generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide
We present a hypothetical case study to examine the use of a next‐generation framework developed by the Genetic Toxicology Technical Committee of the Health and Environmental Sciences Institute for assessing the potential risk of genetic damage from a pharmaceutical perspective. We used etoposide, a...
Autores principales: | Nicolette, John, Luijten, Mirjam, Sasaki, Jennifer C., Custer, Laura, Embry, Michelle, Froetschl, Roland, Johnson, George, Ouedraogo, Gladys, Settivari, Raja, Thybaud, Veronique, Dearfield, Kerry L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299499/ https://www.ncbi.nlm.nih.gov/pubmed/34775645 http://dx.doi.org/10.1002/em.22467 |
Ejemplares similares
-
Utility of a next generation framework for assessment of genomic damage: A case study using the industrial chemical benzene
por: Luijten, Mirjam, et al.
Publicado: (2019) -
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997) -
Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997) -
Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
por: Wu, Chunsheng, et al.
Publicado: (2020) -
Medicaid Managed Care Encounter Data: What, Why, and Where Next?
por: Howell, Embry M.
Publicado: (1996)